ZA898322B - Method of preventing or reducing eosinophilia - Google Patents
Method of preventing or reducing eosinophiliaInfo
- Publication number
- ZA898322B ZA898322B ZA898322A ZA898322A ZA898322B ZA 898322 B ZA898322 B ZA 898322B ZA 898322 A ZA898322 A ZA 898322A ZA 898322 A ZA898322 A ZA 898322A ZA 898322 B ZA898322 B ZA 898322B
- Authority
- ZA
- South Africa
- Prior art keywords
- preventing
- antagonist
- reducing eosinophilia
- human interleukin
- reducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26690988A | 1988-11-03 | 1988-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA898322B true ZA898322B (en) | 1990-11-28 |
Family
ID=23016493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA898322A ZA898322B (en) | 1988-11-03 | 1989-11-01 | Method of preventing or reducing eosinophilia |
Country Status (17)
Country | Link |
---|---|
EP (2) | EP0441891A1 (xx) |
JP (1) | JPH07563B2 (xx) |
KR (1) | KR960002183B1 (xx) |
AT (1) | ATE98872T1 (xx) |
AU (1) | AU633034B2 (xx) |
CA (1) | CA2002144C (xx) |
DE (1) | DE68911653T2 (xx) |
DK (1) | DK81691D0 (xx) |
ES (1) | ES2062032T3 (xx) |
HK (1) | HK186196A (xx) |
IE (1) | IE63063B1 (xx) |
IL (1) | IL92180A (xx) |
MY (1) | MY107386A (xx) |
NZ (1) | NZ243939A (xx) |
PH (1) | PH26476A (xx) |
WO (1) | WO1990004979A2 (xx) |
ZA (1) | ZA898322B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT67943A (en) * | 1992-02-06 | 1995-05-29 | Schering Corp | Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 |
WO1994017773A2 (en) * | 1993-02-01 | 1994-08-18 | Université Libre de Bruxelles | Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
GB9412230D0 (en) * | 1994-06-17 | 1994-08-10 | Celltech Ltd | Interleukin-5 specific recombiant antibodies |
MX9704779A (es) * | 1994-12-23 | 1997-09-30 | Smithkline Beecham Corp | Antagonistas de interleukina-5 recombinante, utiles en la preparacion de composiciones para el tratamiento de perturbaciones mediadas por interleukina-5. |
US7399837B2 (en) | 1995-12-22 | 2008-07-15 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
US5783184A (en) * | 1994-12-23 | 1998-07-21 | Smithkline Beecham Corporation | Method for treatment and diagnosis of IL-5 mediated disorders |
US5693323A (en) * | 1994-12-23 | 1997-12-02 | Smithkline Beecham Corporation | Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
CA2479927C (en) | 2002-03-29 | 2013-03-12 | Schering Corporation | Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
BRPI0910854A2 (pt) | 2008-03-28 | 2015-10-06 | Glaxosmithkline Llc | métodos de tratamento |
BR112019025736A2 (pt) | 2017-06-06 | 2020-06-30 | Glaxosmithkline Llc | uso de um anticorpo e composições para tratar uma doença e para diminuir uma contagem absoluta de eosinófilo no sangue |
CN109942706A (zh) * | 2017-12-21 | 2019-06-28 | 三生国健药业(上海)股份有限公司 | 结合人il-5的单克隆抗体、其制备方法和用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU632991B2 (en) * | 1987-06-24 | 1993-01-21 | Autoimmune, Inc. | Treatment of autoimmune diseases by oral administration of autoantigens |
-
1989
- 1989-11-01 MY MYPI89001525A patent/MY107386A/en unknown
- 1989-11-01 AT AT89311322T patent/ATE98872T1/de not_active IP Right Cessation
- 1989-11-01 EP EP89913250A patent/EP0441891A1/en active Pending
- 1989-11-01 AU AU46448/89A patent/AU633034B2/en not_active Ceased
- 1989-11-01 WO PCT/US1989/004796 patent/WO1990004979A2/en active Search and Examination
- 1989-11-01 EP EP89311322A patent/EP0367596B1/en not_active Revoked
- 1989-11-01 ES ES89311322T patent/ES2062032T3/es not_active Expired - Lifetime
- 1989-11-01 KR KR1019900701417A patent/KR960002183B1/ko not_active IP Right Cessation
- 1989-11-01 DE DE89311322T patent/DE68911653T2/de not_active Revoked
- 1989-11-01 JP JP2500322A patent/JPH07563B2/ja not_active Expired - Lifetime
- 1989-11-01 IL IL92180A patent/IL92180A/xx not_active IP Right Cessation
- 1989-11-01 ZA ZA898322A patent/ZA898322B/xx unknown
- 1989-11-02 PH PH39451A patent/PH26476A/en unknown
- 1989-11-02 IE IE352589A patent/IE63063B1/en not_active IP Right Cessation
- 1989-11-02 CA CA002002144A patent/CA2002144C/en not_active Expired - Lifetime
-
1991
- 1991-05-02 DK DK91816A patent/DK81691D0/da not_active Application Discontinuation
-
1992
- 1992-08-13 NZ NZ243939A patent/NZ243939A/en unknown
-
1996
- 1996-10-03 HK HK186196A patent/HK186196A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR960002183B1 (ko) | 1996-02-13 |
HK186196A (en) | 1996-10-11 |
IE893525L (en) | 1990-05-03 |
IE63063B1 (en) | 1995-03-22 |
MY107386A (en) | 1995-11-30 |
CA2002144A1 (en) | 1990-05-03 |
JPH03505211A (ja) | 1991-11-14 |
CA2002144C (en) | 2000-03-28 |
IL92180A0 (en) | 1990-07-26 |
DE68911653T2 (de) | 1994-04-07 |
IL92180A (en) | 1997-04-15 |
EP0367596B1 (en) | 1993-12-22 |
AU633034B2 (en) | 1993-01-21 |
NZ243939A (en) | 1997-07-27 |
ATE98872T1 (de) | 1994-01-15 |
DE68911653D1 (de) | 1994-02-10 |
PH26476A (en) | 1992-07-27 |
EP0367596A1 (en) | 1990-05-09 |
DK81691A (da) | 1991-05-02 |
JPH07563B2 (ja) | 1995-01-11 |
EP0441891A1 (en) | 1991-08-21 |
DK81691D0 (da) | 1991-05-02 |
WO1990004979A2 (en) | 1990-05-17 |
ES2062032T3 (es) | 1994-12-16 |
WO1990004979A8 (en) | 2005-06-16 |
AU4644889A (en) | 1990-05-28 |
KR900701320A (ko) | 1990-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL89124A0 (en) | Method for reducing immunoglobulin e responses | |
EP0597829A4 (en) | NEW MONOCLONAL ANTIBODY DRESSES AGAINST A NEW ANTIGEN ASSOCIATED WITH HUMAN TUMORS. | |
EP0409607A3 (en) | Antibody to human interleukin-6 receptor | |
GR3022969T3 (en) | Products for the treatment of endotoxic shock in a mammal | |
ZA887987B (en) | Monoclonal antibodies against human interleukin-4 and hybridomas producing the same | |
ZA898322B (en) | Method of preventing or reducing eosinophilia | |
EP0216454A3 (en) | Method of promoting animal growth | |
GB8910395D0 (en) | Human monoclonal antibody and hybridoma producing the same | |
WO1991007986A8 (en) | Method of treating septic shock | |
GR3017920T3 (en) | Bcrf1 antagonists for treating epstein-barr virus infections. | |
EP0407430A4 (en) | Therapeutic murine monoclonal antibody | |
CS495286A1 (en) | Mouse lymhocytaric hybridom producing antibody against human choriogonadotropic hormone | |
CS8905415A1 (en) | Murine lymphocyte hybridoma img-czas he-195 producing antibody against human group antigen a |